MedTrace Logo

Pomegranate Extract Biomarker Study in Osteopenic Women

NCT01219140 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2010-10-13

No results posted yet for this study

Summary

Treatment of post-menopausal subjects (with decreased bone mineral density) with pomegranate extract capsules will produce statistically significant changes in biomarkers for bone resorption and formation when compared to subjects receiving placebo.

Conditions

  • Osteopenic Women

Interventions

DIETARY_SUPPLEMENT

2 POMx Capsules

2 POMx Capsules daily

DIETARY_SUPPLEMENT

2 placebo Capsules

2 placebo Capsules daily

Sponsors & Collaborators

  • POM Wonderful LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01219140 on ClinicalTrials.gov